A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 13, Issue 9, Pages 745-755
Publisher
Informa UK Limited
Online
2012-06-30
DOI
10.4161/cbt.20557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- “The Air Got to It:” Exploring a Belief About Surgery for Lung Cancer
- (2016) Horace M. DeLisser et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models
- (2011) J D Predina et al. CANCER GENE THERAPY
- Impact of minimal tumor burden on antibody response to vaccination
- (2011) Soo-Kie Kim et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Dermal Transforming Growth Factor-β Responsiveness Mediates Wound Contraction and Epithelial Closure
- (2009) Magaly Martinez-Ferrer et al. AMERICAN JOURNAL OF PATHOLOGY
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination
- (2009) N. Grinshtein et al. CANCER RESEARCH
- Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
- (2009) A. Fontana et al. CLINICAL CANCER RESEARCH
- Systemic Inhibition of Transforming Growth Factor- in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
- (2009) R. Ueda et al. CLINICAL CANCER RESEARCH
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery
- (2009) J. Alsousou et al. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
- In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation
- (2009) H. Kishimoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms Driving Local Breast Cancer Recurrence in a Model of Breast-Conserving Surgery
- (2008) Myles J. Smith et al. ANNALS OF SURGICAL ONCOLOGY
- Systemic Blockade of Transforming Growth Factor- Signaling Augments the Efficacy of Immunogene Therapy
- (2008) S. Kim et al. CANCER RESEARCH
- Acute Wounds Accelerate Tumorigenesis by a T Cell-Dependent Mechanism
- (2008) C. H. Stuelten et al. CANCER RESEARCH
- Transforming Growth Factor- Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
- (2008) A. Wallace et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started